Progress Is Being Made Toward Approval Of Generic Biotechnology Drugs

The U.S. slowly is making progress toward developing a regulatory pathway that would allow FDA to approve generic versions of biotechnology drugs, experts from the generic drug industry told attendees of the 10th annual International Generic Pharmaceutical Alliance conference in Miami Beach on Thursday, the [click link for full article]

More: continued here

Filed under: Pharma Industry on December 6th, 2007